Skip to main content

Advertisement

SpringerLink
Log in

Herbs Used for the Treatment of Hypertension and their Mechanism of Action

  • Antihypertensive Agents: Mechanisms of Drug Action (ME Ernst, Section Editor)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

There is great interest lately, in the use of herbs for the treatment of hypertension and cardiovascular disease (CVD). Herbs and plants contain many phytochemicals that have been effective in the treatment of CVD and hypertension. Accumulating scientific evidence provides a reason for the use of herbs by health practitioners for treating their patients. The rationale for this expanding use of herbs is the belief of patients in a “holistic medicine” and that herbs are natural, safe, and effective. However, there are reasons of concern with the use of herbs, because they are not regulated or supervised carefully and their use could lead to serious complications or interactions with their combination with traditional medicines. In addition, their use is associated with significant out of pocket expenses, because their use is not compensated by health insurance providers. In this review, we present the scientific evidence for the use of herbs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States. Natl Health Stat Rep. 2007;2008:1–23.

    Google Scholar 

  2. Yeh GY, Davis RB, Phillips RS. Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol. 2006;98:673–80.

    Article  PubMed  Google Scholar 

  3. Brook RD, Appel LJ, Rubenfire M, Ogedegbe G, Bisignano JD, Elliott WJ, et al. Beyond medications and diet: alternative approaches to lowering blood pressure. A scientific statement from the American Heart Association. Hypertension. 2013;61:1360–83.

    Article  CAS  PubMed  Google Scholar 

  4. • Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4:177. An informative paper describing the growing use of herbs and the issues regarding their regulation and possible adverse effects from their use

    Article  PubMed  PubMed Central  Google Scholar 

  5. • Chysant SG. The clinical significance and costs of herbs and food supplements used by complementary and alternative medicine for the treatment of cardiovascular diseases and hypertension. J Hum Hypertens. 2016;30:1–6. A review describing the use of herbs and food supplements and the costs of CAM for the treatment of hypertension and CVD

    Article  Google Scholar 

  6. Susalit E, Agus N, Effendi L, Tjandrawinata RR, Nofiadny D, Perrinjaquet-Moccetti T, et al. Olive (Olea europaea) leaf extra effective in patients with stage-1 hypertension: comparison with captopril. Phytomedicine. 2011;18:251–8.

    Article  CAS  PubMed  Google Scholar 

  7. Tabassum N, Ahmad F. Role of natural herbs in the treatment of hypertension. Pharmacogn Rev. 2011;5:30–40.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Honda K, Jacobson JS. Use of complementary and alternative medicine among United States adults: the influence of personality, coping strategies, and social support. Prev Med. 2005;40:46–53.

    Article  PubMed  Google Scholar 

  9. Bishop FL, Yardley L, Lewith GT. Why consumers maintain complementary and alternative medicine use: a qualitative study. J Altern Complement Med. 2010;16:175–82.

    Article  PubMed  Google Scholar 

  10. WHO. Traditional Medicine (CVDs), Geneva: World Health Organization, 2014–2023.

  11. Pan SY, Zhou SF, Gao SH, Yu ZL, Zhang SF, Tang MK, et al. New perspectives on how to discover drugs from herbal medicines: CAMs outstanding contribution to modern therapeutics. Evid Based Complement Alternat Med. 2013;2013:627375.

    PubMed  PubMed Central  Google Scholar 

  12. • Liu C. Huang Y. Chinese herbal medicine on cardiovascular diseases and the mechanism of action. Front Pharmacol. 2016;7:469. Comprehensive review of traditional and Chinese medicine for the treatment of hypertension and CVD

    PubMed  PubMed Central  Google Scholar 

  13. • Braun LA, Tiralongo E, Wilkinson JM, Poole S, Spitzer O, Bailey M, et al. Perceptions, use and attitudes of pharmacy customers on complementary medicines and pharmacy practice. BMJ Complement Altern Med. 2010;10:38. Informative paper describing the various reasons and perceptions as to why people use herbs and CAM for the treatment of various ailments

    Article  Google Scholar 

  14. Anquez-Traxler C. The legal and regulatory framework of herbal medicinal products in the European Union: focus on the traditional herbal medicines category. Drug Inf J. 2011;45:15–23.

    Article  Google Scholar 

  15. • Al Disi SS, Anwar MA, Eid AH. Anti-hypertensive herbs and their mechanisms of action: part I. Front Pharmacol. 2016;6:323. Comprehensive review about the beneficial effects of many herbs for the treatment of hypertension and CVDs

    PubMed  PubMed Central  Google Scholar 

  16. Ried K, Travica N, Sali A. The effect of aged garlic extract on blood pressure and other cardiovascular risk factors in uncontrolled hypertensives: the AGE at heart trial. Integr Blood Press Control. 2016;9:9–21.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Rohner A, Ried K, Sobenin IA, Bucher HC, Nordman AJ. A systematic review and meta-analysis on the effects of garlic preparations on blood pressure in individuals with hypertension. Am J Hypertens. 2015;28:414–23.

    Article  PubMed  Google Scholar 

  18. Wang HP, Yang J, Qin LQ, Yang XJ. Effect of garlic on blood pressure: a meta-analysis. J Clin Hypertens. 2015;17:223–31.

    Article  Google Scholar 

  19. Ried K. Garlic lowers blood pressure in hypertensive individuals, regulates serum cholesterol, and stimulates immunity: an updated meta-analysis and review. J Nutr. 2016;146(Suppl):389S–96S.

    Article  CAS  PubMed  Google Scholar 

  20. Morihara N, Hino A. Aged garlic extract suppresses platelet aggregation by changing the functional property of platelets. J Nat Med. 2017;71:249–56.

    Article  PubMed  Google Scholar 

  21. • Kapil V, Khambata RS, Robertson A, Caulfield MJ, Ahluwalia A. Dietary nitrate provides sustained blood pressure lowering in hypertensive patients. A randomized, phase 2, double-blind, placebo-controlled study. Hypertension. 2015;65:320–7. A study describing a new concept for treating hypertension by providing exogenous nitrate to increase levels of endogenous nitrite and NO, which is depleted in hypertensive patients

    Article  CAS  PubMed  Google Scholar 

  22. Bondonno CP, Liu AH, Croft KD, Ward NC, Shinde S, Moodley Y, et al. Absence of an effect of high nitrate intake from beetroot juice on blood pressure in treated hypertensive individuals: a randomized controlled trial. Am J Clin Nutr. 2015;102:368–75.

    Article  CAS  PubMed  Google Scholar 

  23. Hodgson JM, Puddey IB, Woodman RJ, Mulder TP, Fuchs D, Scott K, et al. Effects of black tea on blood pressure: a randomized controlled trial. Arch Intern Med. 2012;172:186–8.

    Article  PubMed  Google Scholar 

  24. Hartley L, Flowers N, Holmes J, Clarke A, Stranges S, Hooper L, et al. Green and black tea for primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;6:CD009934.

    Google Scholar 

  25. Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J, et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipidemia and hypertension. J Ethnopharmcol. 2015;161:69–81.

    Article  CAS  Google Scholar 

  26. Affuso F, Mercurio V, Fazio V, Fazio S. Cardiovascular and metabolic effects of berberine. World J Cardiol. 2010;2:71–7.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Tassel MC, Kingston R, Gilroy D, Lehane M, Furrey A. Hauthorn (Crataegus spp) in the treatment of cardiovascular disease. Pharmacogn Rev. 2010;4:32–41.

    Article  Google Scholar 

  28. Walker AF, Marakis G, Morris AP, Robinson PA. Promising hypotensive effect of hawthorn extract: a randomized double-blind study of mild, essential hypertension. Phytother Res. 2002;16:48–54.

    Article  PubMed  Google Scholar 

  29. Asher GN, Viera AJ, Weaver MA, Dominik R, Caughey M, Hinderliter AL. Effect of hawthorn standardized extract on flow mediated dilation in prehypertensive and mildly hypertensive adults: a randomized, controlled cross-over trial. BMC Complement Altern Med. 2012;12:26.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Srivastava R, Ahmed, Dharamveer, Saraf SA. Crocus sativus L.: a comprehensive review. Pharmacogn Rev. 2010;4:200–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Fatechi M, Rashidabady T, Fatechi-Hassanabad Z. Effects of Crocus sativus petal’s extract on rat blood pressure and on responses induced by electrical field stimulation in the rat isolated vas deferens and guinea-pig ileum. J Ethnopharmacol. 2003;84:199–203.

    Article  Google Scholar 

  32. Imenshahidi M, Razavi BM, Faal A, Gholampoor A, Mousavi SM, Hosseinzadeh H. The effect of chronic administration of safranal on systolic blood pressure in rats. Iran J Pharm Res. 2015;14:585–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Modaghegh MH, Shahabian M, Esmaelli HA, Rajbai O, Hosseinzadeh H. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine. 2008;15:1032–7.

    Article  PubMed  Google Scholar 

  34. Inuwa I, Ali BH, Al-Lawati I, Beegam S, Blunden G. Long-term ingestion of hibiscus sabdariffa calyx extract enhances myocardial capillarization in the spontaneously hypertensive rat. Exp Biol Med. 2012;237:563–9.

    Article  CAS  Google Scholar 

  35. Herrera-Arellano A, Miranda-Sanchez J, Avila-Castro P, Herrera-Alvarez S, Jimenez-Ferrer JE, Zamilpa A, et al. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. Planta Med. 2007;73:6–12.

    Article  CAS  PubMed  Google Scholar 

  36. McKay DL, Chen CY, Saltzman E, Blumberg JB. HIbiscus sabdariffa L, tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. J Nutr. 2010;140:298–303.

    Article  CAS  PubMed  Google Scholar 

  37. Alarcon-Alonso J, Zamilpa A, Aguilar FA, Herrera-Ruiz M, Tortoriello J, Jimenez-Ferrer E. Pharmacological characterization of the diuretic effect of Hibiscus sabdariffa Linn (Malvaceae) extract. J Ethnopharmacol. 2012;139:751–6.

    Article  CAS  PubMed  Google Scholar 

  38. Ajay M, Chai HJ, Nustafa AM, Gilani AH, Mustafa MR. Mechanisms of anti-hypertensive effect of Hibiscus sabdariffa L, calyces. J Ethnopharmacol. 2007;109:388–93.

    Article  CAS  PubMed  Google Scholar 

  39. Sarr M, Ngom S, Kane MO, Wele A, Diop D, Sarr B, et al. In vitro vasorelaxation mechanisms of bioactive compounds extracted from Hibiscus sabdariffa on rat thoracic aorta. Nutr Metab. 2009;6:45.

    Article  Google Scholar 

  40. Leong XF, Mustafa MR, Jaarin K. Nigella sativa and its protective role in oxidative stress and hypertension. Evid Based Complement Alternat Med. 2013;120732

  41. Zaoui A, Cherrah Y, Lacaille-Dubois MA, Settaf A, Amarouch H, Hassar M. Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat. Therapie. 2000;55:370–82.

    Google Scholar 

  42. Khattab MM, Nagi MN. Thymoquinone supplementation attenuates hypertension and renal damage in nitric oxide deficient hypertensive rats. Phytother Res. 2007;21:410–4.

    Article  CAS  PubMed  Google Scholar 

  43. Fallah Huseini H, Amini M, Mohtashami R, Ghamarchehre ME, Sadeqhi Z, Kianbakht S, et al. Blood pressure lowering effect of nigella sativa L. seed oil in healthy volunteers: a randomized, double-blind, placebo-controlled clinical trial. Phytother Res. 2013;27:1849–53.

    Article  CAS  PubMed  Google Scholar 

  44. Dehkordi FR, Kamkhah AF. Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundam Clin Pharmacol. 2008;22:447–52.

    Article  CAS  PubMed  Google Scholar 

  45. Valli G, Giardina EG. Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. J Am Coll Cardiol. 2002;39:1083–95.

    Article  PubMed  Google Scholar 

  46. Mucalo I, Jovanovski E, Rahelic D, Bozikov V, Romic Z, Vuksan V. Effect of American ginseng (Panax quinquefolius L) on arterial stiffness in subjects with type-2 diabetes and concomitant hypertension. J Ethnopharmacol. 2013;150:148–53.

    Article  CAS  PubMed  Google Scholar 

  47. Jovanovski E, Bateman EA, Bhardwaj J, Fairgrieve C, Mucalo I, Jenkins AL, et al. Effect of Rg3-enriched Korean red ginseng (Panax ginseng) on arterial stiffness and blood pressure in healthy individuals: a randomized controlled trial. J Am Soc Hypertens. 2014;8:537–41.

    Article  CAS  PubMed  Google Scholar 

  48. Kim JH. Cardiovascular diseases and Panax ginseng: a review on molecular mechanisms and medical applications. J Ginseng Res. 2012;36:16–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Rhee MY, Cho B, Kim KI, Kim J, Kim MK, Lee EK, et al. Blood pressure lowering effect of Korean ginseng derived ginseol K-g1. Am J Chin Med. 2014;42:605–18.

    Article  CAS  PubMed  Google Scholar 

  50. Ng CF, Koon CM, Cheung DW, Lam MY, Leung PC, Lau CB, et al. The anti-hypertensive effect of Danshen (Salvia miltiorrhiza) and Gegen (Pueraria lobata) formula in rats and its underlying mechanisms of vasorelaxation. J Ethnopharmacol. 2011;137:1366–72.

    Article  CAS  PubMed  Google Scholar 

  51. Zhang J, An SJ, Fu JQ, Liu P, Shao TM, Li M, et al. Mixed aqueous extract of Salvia miltiorrhiza reduces blood pressure through inhibition of vascular remodeling and oxidative stress in spontaneously hypertensive rats. Cell Physiol Biochem. 2016;40:347–60.

    Article  CAS  PubMed  Google Scholar 

  52. Yang TY, Wei JC, Lee MY, Chen CM, Ueng KC. A randomized, double-blind, placebo-controlled study to evaluate the efficacy and tolerability of fufang danshen (salvia miltiorrhiza) as add-on antihypertensive therapy in Taiwanese patients with uncontrolled hypertension. Phytother Res. 2012;26:291–8.

    Article  PubMed  Google Scholar 

  53. Awang K, Abdullah NH, Hadi AH, Fong YS. Cardiovascular activity of Labdane ditererpenes from andrographis paniculata in isolated rat hearts. J Biomed Biotechnol. 2012;876458

  54. Moghadam MH, Imenshahidi M, Mohajeri SA. Antihypertensive effect of celery seed on rat blood pressure in chronic administration. J Med Food. 2013;16:558–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Bartolome AP, Villsenor IM, Yang WC. Bidens pilosa L (asteraceae): botanical properties, traditional uses, phytochemistry, and pharmacology. Evid Based Complement Alternat Med. 2013;340215

  56. Jabeen Q, Bashir S, Lyoussi B, Gilani AH. Coriander fruit exhibits gut modulatory, blood pressure lowering and diuretic activities. J Ethnopharmacol. 2009;122:123–30.

    Article  PubMed  Google Scholar 

  57. Devi RC, Sim SM, Ismail R. Effect of cymbopogon citrates and citral on vascular smooth muscle of the isolated thoracic rat aorta. Evid Based Complement Alternat Med. 2012;539475

  58. Hao P, Jiang F, Cheng J, Ma L, Zhang Y, Zhao Y. Traditional Chinese medicine for cardiovascular disease. J Am Coll Cardiol. 2017;69:2952–66.

    Article  PubMed  Google Scholar 

  59. Dzeuflet PD, Moqueo A, Bilanda DC, Aboubakar BF, Tedong L, Dimo T, et al. Antihypertensive potential of the aqueous extract which combine leaf of persea Americana mill. (Lauraceae), stems and leaf of cymbopogon citrates (D.C) Stapf. (Poaceae), fruits of citrus medicinal L. (Rutaceae) as well as honey in inethanol and sucrose experimental model. BMC Complement Altern Med. 2014;14:507.

    Article  Google Scholar 

  60. Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med. 2003;139:761–76.

    Article  CAS  PubMed  Google Scholar 

  61. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Marx SO, Totary-Jain H, Marks AR. Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv. 2011;4:104–11.

    Article  CAS  PubMed  Google Scholar 

  63. Ma TK, Kam KK, Yan BP, Lam YY. Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol. 2010;160:1273–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Iglarz M, Clozel M. Mechanisms of ET-1 induced endothelial dysfunction. J Cardiovasc Pharmacol. 2007;50:621–8.

    Article  CAS  PubMed  Google Scholar 

  65. Virdis A, Duranti E, Taddei S. Oxidative stress and vascular damage in hypertension: role of angiotensin II. Int J Hypertens. 2011;916310

  66. Montezano AC, Tsiropoulou S, Dulak-Lis M, Harvey A, De Lucca CL, Touyz R. Redox signaling, Nox5 and vascular remodeling in hypertension. Curr Opin Nephrol Hypertens. 2015;24

  67. MacKay CE, Knock GA. Control of vascular smooth muscle function by Src− family kinases and reactive oxygen species in health and disease. J Physiol. 2015;593:3815–28.

    Article  CAS  PubMed  Google Scholar 

  68. • Tachjian A, Maria V, Jabangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol. 2010;55:515–25. Paper describing the potential dangers from consumption of unregulated herbs due to adulteration with toxic substances

    Article  PubMed  PubMed Central  Google Scholar 

  69. Raynor DK, Dickinson R, Knapp P, Long AF, Nicolson DJ. Buyer beware? Does the information provided with herbal products available over the counter enable safe use? BMC Med. 2011;9:94.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Saper RB, Phillips RS, Sehgal A, Khouri N, Davis RB, Paquin J, et al. Lead, mercury, and arsenic in US and Indian manufactured ayurvedic medicines sold via the internet. JAMA. 2008;300:915–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Oklahoma College of Medicine, Oklahoma, OK, USA

    Steven G. Chrysant

  2. INTEGRIS Baptist Medical Center, 5700 Mistletoe Court, Oklahoma, OK, 73142, USA

    George S. Chrysant

Authors
  1. Steven G. Chrysant
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George S. Chrysant
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven G. Chrysant.

Ethics declarations

Conflict of Interest

The authors declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Antihypertensive Agents: Mechanisms of Drug Action

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chrysant, S.G., Chrysant, G.S. Herbs Used for the Treatment of Hypertension and their Mechanism of Action. Curr Hypertens Rep 19, 77 (2017). https://doi.org/10.1007/s11906-017-0775-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11906-017-0775-5

Keywords

Search

Navigation